Theravance Biopharma, Inc. (TBPH) · Insider trading
What Theravance Biopharma's directors, officers and largest holders bought and sold themselves, from the Form 4 each of them files with the SEC within two business days of a trade. Open-market purchases and sales first: those are the trades somebody chose to make at the market price.
Bought, 12 months
$0
0 insiders, 0 trades
Sold, 12 months
$8.77M
3 insiders, 23% under a plan
Net, 12 months
−$8.77M
bought less sold
Latest filing
2026-09-28
filings read to 2026-10-19
Who traded, two years
| Insider | Bought | Sold | Trades | Last trade | Holds after |
|---|---|---|---|---|---|
| Samaha Eli10% owner | – | $5.91M | 5 | 2026-07-07 | – |
| Farnum RhondaSVP, COMM & MEDICAL AFFAIRS | – | $1.95M | 19 | 2026-09-15 | 223,461 |
| Broshy EranDirector | – | $1.40M | 5 | 2025-11-26 | 60,204 |
Open-market purchases and sales
Newest first. “Plan” marks a trade made under a 10b5-1 plan set up in advance.
| Date | Insider | Trade | Shares | Price | Value | Holds after | Filing |
|---|---|---|---|---|---|---|---|
| 2026-09-15 | Farnum RhondaSVP, COMM & MEDICAL AFFAIRS | Saleplan | 3,329 | 17.03 | $56,693 | 223,461 | Form 4 |
| 2026-09-15 | Farnum RhondaSVP, COMM & MEDICAL AFFAIRS | Saleplan | 3,328 | 17.03 | $56,676 | 220,133 | Form 4 |
| 2026-09-15 | Farnum RhondaSVP, COMM & MEDICAL AFFAIRS | Saleplan | 6,657 | 17.03 | $113,369 | 213,476 | Form 4 |
| 2026-07-07 | Samaha Eli10% owner | Saleindirect | 5,564 | 17.17 | $95,534 | 9,167,489 | Form 4 |
| 2026-07-06 | Samaha Eli10% owner | Saleindirect | 1,400 | 17.04 | $23,856 | 9,173,053 | Form 4 |
| 2026-07-01 | Samaha Eli10% owner | Saleindirect | 37,799 | 17.00 | $642,583 | 9,174,453 | Form 4 |
| 2026-06-30 | Samaha Eli10% owner | Saleindirect | 25,027 | 17.13 | $428,713 | 9,212,252 | Form 4 |
| 2026-06-29 | Samaha Eli10% owner | Saleindirect | 273,871 | 17.23 | $4.72M | 9,237,279 | Form 4 |
| 2026-06-15 | Farnum RhondaSVP, COMM & MEDICAL AFFAIRS | Saleplan | 3,329 | 16.39 | $54,562 | 242,442 | Form 4 |
| 2026-06-15 | Farnum RhondaSVP, COMM & MEDICAL AFFAIRS | Saleplan | 3,328 | 16.38 | $54,513 | 239,114 | Form 4 |
| 2026-06-15 | Farnum RhondaSVP, COMM & MEDICAL AFFAIRS | Saleplan | 6,657 | 16.39 | $109,108 | 232,457 | Form 4 |
| 2026-03-16 | Farnum RhondaSVP, COMM & MEDICAL AFFAIRS | Saleplan | 7,767 | 13.92 | $108,117 | 255,999 | Form 4 |
| 2026-03-16 | Farnum RhondaSVP, COMM & MEDICAL AFFAIRS | Saleplan | 15,534 | 14.00 | $217,476 | 240,465 | Form 4 |
| 2026-03-16 | Farnum RhondaSVP, COMM & MEDICAL AFFAIRS | Saleplan | 7,766 | 13.92 | $108,103 | 232,699 | Form 4 |
| 2025-12-03 | Farnum RhondaSVP, COMM & MEDICAL AFFAIRS | Saleplan | 7,767 | 18.75 | $145,631 | 300,995 | Form 4 |
| 2025-12-03 | Farnum RhondaSVP, COMM & MEDICAL AFFAIRS | Saleplan | 7,766 | 18.75 | $145,612 | 293,229 | Form 4 |
| 2025-12-03 | Farnum RhondaSVP, COMM & MEDICAL AFFAIRS | Saleplan | 15,534 | 18.75 | $291,262 | 277,695 | Form 4 |
| 2025-11-26 | Broshy EranDirector | Saleplan | 14,000 | 20.00 | $280,000 | 60,204 | Form 4 |
| 2025-11-26 | Broshy EranDirector | Saleplan | 15,501 | 20.00 | $310,020 | 44,703 | Form 4 |
| 2025-11-11 | Broshy EranDirector | Sale | 15,500 | 18.50 | $286,750 | 75,704 | Form 4/A |
| 2025-11-11 | Broshy EranDirector | Sale | 15,500 | 17.00 | $263,500 | 60,204 | Form 4/A |
| 2025-11-11 | Broshy EranDirector | Sale | 14,000 | 18.50 | $259,000 | 60,204 | Form 4/A |
| 2025-07-14 | Farnum RhondaSVP, COMM & MEDICAL AFFAIRS | Saleplan | 682 | 11.39 | $7,768 | 336,236 | Form 4 |
| 2025-07-14 | Farnum RhondaSVP, COMM & MEDICAL AFFAIRS | Saleplan | 5,318 | 11.39 | $60,572 | 330,918 | Form 4 |
| 2025-07-14 | Farnum RhondaSVP, COMM & MEDICAL AFFAIRS | Saleplan | 4,000 | 11.39 | $45,560 | 326,918 | Form 4 |
| 2025-06-02 | Farnum RhondaSVP, COMM & MEDICAL AFFAIRS | Saleplan | 24,000 | 11.00 | $264,000 | 336,918 | Form 4 |
| 2025-04-21 | Farnum RhondaSVP, COMM & MEDICAL AFFAIRS | Saleplan | 4,000 | 9.00 | $36,000 | 370,038 | Form 4 |
| 2025-01-21 | Farnum RhondaSVP, COMM & MEDICAL AFFAIRS | Saleplan | 4,000 | 9.00 | $36,000 | 309,565 | Form 4 |
| 2024-11-11 | Farnum RhondaSVP, COMM & MEDICAL AFFAIRS | Sale | 4,000 | 9.00 | $36,000 | 322,743 | Form 4 |
Grants, exercises and other transactions
Pay, tax and paperwork rather than a choice to trade at the market price. Two years.
40 × shares withheld for tax25 × returned to the company25 × grant or award5 × gift1 × other
Show them
| Date | Insider | What | Shares | Price | Holds after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-23 | Weiss Asset Management LPOther | Other J | −7,457,060 | 17.00 | 0 | Form 4 |
| 2026-09-23 | Mitchell Dean JDirector | Returned to the company D | −91,204 | – | 6,009 | Form 4 |
| 2026-09-23 | Mitchell Dean JDirector | Returned to the company D | −6,009 | – | 0 | Form 4 |
| 2026-09-23 | Pakianathan DeepikaDirector | Returned to the company D | −58,065 | – | 6,009 | Form 4 |
| 2026-09-23 | Pakianathan DeepikaDirector | Returned to the company D | −6,009 | – | 0 | Form 4 |
| 2026-09-23 | Winningham Rick EDirector, CHIEF EXECUTIVE OFFICER | Returned to the company D | −1,382,272 | – | 228,750 | Form 4 |
| 2026-09-23 | Winningham Rick EDirector, CHIEF EXECUTIVE OFFICER | Returned to the company D | −151,875 | – | 76,875 | Form 4 |
| 2026-09-23 | Winningham Rick EDirector, CHIEF EXECUTIVE OFFICER | Returned to the company D | −76,875 | – | 0 | Form 4 |
| 2026-09-23 | Winningham Rick EDirector, CHIEF EXECUTIVE OFFICER | Returned to the company D | −23,400 | – | 0 | Form 4 |
| 2026-09-23 | Winningham Rick EDirector, CHIEF EXECUTIVE OFFICER | Returned to the company D | −92,567 | – | 0 | Form 4 |
| 2026-09-23 | Smaldone Alsup LaurieDirector | Returned to the company D | −74,980 | – | 6,009 | Form 4 |
| 2026-09-23 | Smaldone Alsup LaurieDirector | Returned to the company D | −6,009 | – | 0 | Form 4 |
| 2026-09-23 | O'Connor DonalDirector | Returned to the company D | −74,204 | – | 6,009 | Form 4 |
| 2026-09-23 | O'Connor DonalDirector | Returned to the company D | −6,009 | – | 0 | Form 4 |
| 2026-09-23 | Gray SusannahDirector | Returned to the company D | −42,137 | – | 6,009 | Form 4 |
| 2026-09-23 | Gray SusannahDirector | Returned to the company D | −6,009 | – | 0 | Form 4 |
| 2026-09-23 | Farnum RhondaSVP, COMM & MEDICAL AFFAIRS | Returned to the company D | −124,414 | – | 89,062 | Form 4 |
| 2026-09-23 | Farnum RhondaSVP, COMM & MEDICAL AFFAIRS | Returned to the company D | −89,062 | – | 0 | Form 4 |
| 2026-09-23 | Sawaf AzizSVP & CHIEF FINANCIAL OFFICER | Returned to the company D | −204,966 | – | 131,875 | Form 4 |
| 2026-09-23 | Sawaf AzizSVP & CHIEF FINANCIAL OFFICER | Returned to the company D | −108,436 | – | 23,439 | Form 4 |
| 2026-09-23 | Sawaf AzizSVP & CHIEF FINANCIAL OFFICER | Returned to the company D | −23,439 | – | 0 | Form 4 |
| 2026-09-23 | Grimaud Brett A.SVP, GEN COUNSEL AND SECRETARY | Returned to the company D | −223,917 | – | 131,251 | Form 4 |
| 2026-09-23 | Grimaud Brett A.SVP, GEN COUNSEL AND SECRETARY | Returned to the company D | −107,812 | – | 23,439 | Form 4 |
| 2026-09-23 | Grimaud Brett A.SVP, GEN COUNSEL AND SECRETARY | Returned to the company D | −23,439 | – | 0 | Form 4 |
| 2026-09-23 | Miller AineSVP, DEV & HEAD OF IRE OFFICE | Returned to the company D | −93,108 | – | 96,718 | Form 4 |
| 2026-09-23 | Miller AineSVP, DEV & HEAD OF IRE OFFICE | Returned to the company D | −96,718 | – | 0 | Form 4 |
| 2026-08-20 | Winningham Rick EDirector, CHIEF EXECUTIVE OFFICER | Shares withheld for tax F | −20,034 | 16.95 | 1,611,022 | Form 4 |
| 2026-08-20 | Farnum RhondaSVP, COMM & MEDICAL AFFAIRS | Shares withheld for tax F | −5,667 | 16.95 | 226,790 | Form 4 |
| 2026-08-20 | Sawaf AzizSVP & CHIEF FINANCIAL OFFICER | Shares withheld for tax F | −8,112 | 16.95 | 336,841 | Form 4 |
| 2026-08-20 | Grimaud Brett A.SVP, GEN COUNSEL AND SECRETARY | Shares withheld for tax F | −7,952 | 16.95 | 355,168 | Form 4 |
| 2026-08-20 | Miller AineSVP, DEV & HEAD OF IRE OFFICE | Shares withheld for tax F | −6,258 | 16.95 | 189,826 | Form 4 |
| 2026-06-19 | Miller AineSVP, DEV & HEAD OF IRE OFFICE | Grant or award A | +18,750 | – | 196,084 | Form 4 |
| 2026-06-12 | Mitchell Dean JDirector | Grant or award A | +6,009 | – | 97,213 | Form 4 |
| 2026-06-12 | Pakianathan DeepikaDirector | Grant or award A | +6,009 | – | 64,074 | Form 4 |
| 2026-06-12 | Smaldone Alsup LaurieDirector | Grant or award A | +6,009 | – | 80,989 | Form 4 |
| 2026-06-12 | O'Connor DonalDirector | Grant or award A | +6,009 | – | 80,213 | Form 4 |
| 2026-06-12 | Gray SusannahDirector | Grant or award A | +6,009 | – | 48,146 | Form 4 |
| 2026-05-20 | Winningham Rick EDirector, CHIEF EXECUTIVE OFFICER | Shares withheld for tax F | −20,038 | 16.55 | 1,631,056 | Form 4 |
| 2026-05-20 | Farnum RhondaSVP, COMM & MEDICAL AFFAIRS | Shares withheld for tax F | −5,678 | 16.55 | 245,771 | Form 4 |
| 2026-05-20 | Sawaf AzizSVP & CHIEF FINANCIAL OFFICER | Shares withheld for tax F | −8,670 | 16.55 | 344,953 | Form 4 |
| 2026-05-20 | Grimaud Brett A.SVP, GEN COUNSEL AND SECRETARY | Shares withheld for tax F | −8,829 | 16.55 | 363,120 | Form 4 |
| 2026-05-20 | Miller AineSVP, DEV & HEAD OF IRE OFFICE | Shares withheld for tax F | −6,827 | 16.55 | 177,334 | Form 4 |
| 2026-04-01 | Winningham Rick EDirector, CHIEF EXECUTIVE OFFICER | Grant or award A | +75,000 | – | 1,651,094 | Form 4 |
| 2026-04-01 | Farnum RhondaSVP, COMM & MEDICAL AFFAIRS | Grant or award A | +18,750 | – | 251,449 | Form 4 |
| 2026-04-01 | Sawaf AzizSVP & CHIEF FINANCIAL OFFICER | Grant or award A | +37,500 | – | 353,623 | Form 4 |
| 2026-04-01 | Grimaud Brett A.SVP, GEN COUNSEL AND SECRETARY | Grant or award A | +37,500 | – | 371,949 | Form 4 |
| 2026-02-20 | Winningham Rick EDirector, CHIEF EXECUTIVE OFFICER | Shares withheld for tax F | −74,975 | 19.66 | 1,576,094 | Form 4 |
| 2026-02-20 | Farnum RhondaSVP, COMM & MEDICAL AFFAIRS | Shares withheld for tax F | −13,929 | 19.66 | 263,766 | Form 4 |
| 2026-02-20 | Sawaf AzizSVP & CHIEF FINANCIAL OFFICER | Shares withheld for tax F | −20,672 | 19.66 | 316,123 | Form 4 |
| 2026-02-20 | Grimaud Brett A.SVP, GEN COUNSEL AND SECRETARY | Shares withheld for tax F | −20,833 | 19.66 | 334,449 | Form 4 |
| 2026-02-20 | Miller AineSVP, DEV & HEAD OF IRE OFFICE | Shares withheld for tax F | −16,851 | 19.66 | 184,161 | Form 4 |
| 2025-11-20 | Farnum RhondaSVP, COMM & MEDICAL AFFAIRS | Shares withheld for tax F | −9,060 | 17.90 | 308,762 | Form 4 |
| 2025-11-20 | Sawaf AzizSVP & CHIEF FINANCIAL OFFICER | Shares withheld for tax F | −18,627 | 17.90 | 336,795 | Form 4 |
| 2025-11-20 | Grimaud Brett A.SVP, GEN COUNSEL AND SECRETARY | Shares withheld for tax F | −19,024 | 17.90 | 355,282 | Form 4 |
| 2025-11-20 | Miller AineSVP, DEV & HEAD OF IRE OFFICE | Shares withheld for tax F | −6,989 | 17.90 | 201,012 | Form 4 |
| 2025-11-20 | Winningham Rick EDirector, CHIEF EXECUTIVE OFFICER | Shares withheld for tax F | −56,817 | 17.90 | 1,651,069 | Form 4 |
| 2025-11-19 | Winningham Rick EDirector, CHIEF EXECUTIVE OFFICER | Gift G | −9,900 | – | 1,707,886 | Form 4 |
| 2025-11-19 | Winningham Rick EDirector, CHIEF EXECUTIVE OFFICER | Gift G | +9,900 | – | 23,400 | Form 4 |
| 2025-08-20 | Farnum RhondaSVP, COMM & MEDICAL AFFAIRS | Shares withheld for tax F | −9,096 | 13.39 | 317,822 | Form 4 |
| 2025-08-20 | Grimaud Brett A.SVP, GEN COUNSEL AND SECRETARY | Shares withheld for tax F | −9,762 | 13.39 | 374,306 | Form 4 |
| 2025-08-20 | Miller AineSVP, DEV & HEAD OF IRE OFFICE | Shares withheld for tax F | −6,989 | 13.39 | 208,001 | Form 4 |
| 2025-08-20 | Sawaf AzizSVP & CHIEF FINANCIAL OFFICER | Shares withheld for tax F | −9,368 | 13.39 | 355,422 | Form 4 |
| 2025-08-20 | Winningham Rick EDirector, CHIEF EXECUTIVE OFFICER | Shares withheld for tax F | −15,394 | 13.39 | 1,717,786 | Form 4 |
| 2025-06-23 | Winningham Rick EDirector, CHIEF EXECUTIVE OFFICER | Gift G | −20,000 | – | 1,733,180 | Form 4 |
| 2025-06-13 | Winningham Rick EDirector, CHIEF EXECUTIVE OFFICER | Gift G | −9,600 | – | 1,753,180 | Form 4 |
| 2025-06-13 | Winningham Rick EDirector, CHIEF EXECUTIVE OFFICER | Gift G | +9,600 | – | 13,500 | Form 4 |
| 2025-05-20 | Farnum RhondaSVP, COMM & MEDICAL AFFAIRS | Shares withheld for tax F | −9,120 | 9.45 | 360,918 | Form 4 |
| 2025-05-20 | Grimaud Brett A.SVP, GEN COUNSEL AND SECRETARY | Shares withheld for tax F | −9,743 | 9.45 | 384,068 | Form 4 |
| 2025-05-20 | Sawaf AzizSVP & CHIEF FINANCIAL OFFICER | Shares withheld for tax F | −9,348 | 9.45 | 364,790 | Form 4 |
| 2025-05-20 | Winningham Rick EDirector, CHIEF EXECUTIVE OFFICER | Shares withheld for tax F | −15,364 | 9.45 | 1,762,780 | Form 4 |
| 2025-05-20 | Miller AineSVP, DEV & HEAD OF IRE OFFICE | Shares withheld for tax F | −9,701 | 9.45 | 214,990 | Form 4 |
| 2025-05-19 | Smaldone Alsup LaurieDirector | Grant or award A | +10,649 | – | 74,980 | Form 4 |
| 2025-05-19 | Broshy EranDirector | Grant or award A | +10,649 | – | 91,204 | Form 4 |
| 2025-05-19 | Grant Jeremy TDirector | Grant or award A | +10,649 | – | 32,954 | Form 4 |
| 2025-05-19 | Gray SusannahDirector | Grant or award A | +10,649 | – | 42,137 | Form 4 |
| 2025-05-19 | Mitchell Dean JDirector | Grant or award A | +10,649 | – | 91,204 | Form 4 |
| 2025-05-19 | O'Connor DonalDirector | Grant or award A | +10,649 | – | 74,204 | Form 4 |
| 2025-05-19 | Pakianathan DeepikaDirector | Grant or award A | +10,649 | – | 58,065 | Form 4 |
| 2025-05-19 | Miller AineSVP, DEV & HEAD OF IRE OFFICE | Grant or award A | +10,430 | – | 224,691 | Form 4 |
| 2025-02-28 | Farnum RhondaSVP, COMM & MEDICAL AFFAIRS | Grant or award A | +75,000 | – | 374,038 | Form 4 |
| 2025-02-28 | Grimaud Brett A.SVP, GEN COUNSEL AND SECRETARY | Grant or award A | +75,000 | – | 393,811 | Form 4 |
| 2025-02-28 | Miller AineSVP, DEV & HEAD OF IRE OFFICE | Grant or award A | +75,000 | – | 214,261 | Form 4 |
| 2025-02-28 | Sawaf AzizSVP & CHIEF FINANCIAL OFFICER | Grant or award A | +75,000 | – | 374,138 | Form 4 |
| 2025-02-28 | Winningham Rick EDirector, CHIEF EXECUTIVE OFFICER | Grant or award A | +2,178 | 9.35 | 1,778,144 | Form 4 |
| 2025-02-20 | Farnum RhondaSVP, COMM & MEDICAL AFFAIRS | Shares withheld for tax F | −15,810 | 9.66 | 299,038 | Form 4 |
| 2025-02-20 | Grimaud Brett A.SVP, GEN COUNSEL AND SECRETARY | Shares withheld for tax F | −14,534 | 9.66 | 318,811 | Form 4 |
| 2025-02-20 | Miller AineSVP, DEV & HEAD OF IRE OFFICE | Shares withheld for tax F | −11,295 | 9.66 | 139,261 | Form 4 |
| 2025-02-20 | Sawaf AzizSVP & CHIEF FINANCIAL OFFICER | Shares withheld for tax F | −13,751 | 9.66 | 299,138 | Form 4 |
| 2025-02-20 | Winningham Rick EDirector, CHIEF EXECUTIVE OFFICER | Shares withheld for tax F | −35,129 | 9.66 | 1,775,966 | Form 4 |
| 2025-02-10 | Farnum RhondaSVP, COMM & MEDICAL AFFAIRS | Grant or award A | +5,283 | – | 314,848 | Form 4 |
| 2024-11-20 | Farnum RhondaSVP, COMM & MEDICAL AFFAIRS | Shares withheld for tax F | −9,178 | 9.97 | 313,565 | Form 4 |
| 2024-11-20 | Grimaud Brett A.SVP, GEN COUNSEL AND SECRETARY | Shares withheld for tax F | −9,268 | 9.97 | 333,345 | Form 4 |
| 2024-11-20 | Miller AineSVP, DEV & HEAD OF IRE OFFICE | Shares withheld for tax F | −10,076 | 9.97 | 150,556 | Form 4 |
| 2024-11-20 | Sawaf AzizSVP & CHIEF FINANCIAL OFFICER | Shares withheld for tax F | −8,477 | 9.97 | 312,889 | Form 4 |
| 2024-11-20 | Winningham Rick EDirector, CHIEF EXECUTIVE OFFICER | Shares withheld for tax F | −15,997 | 9.97 | 1,811,095 | Form 4 |
| 2024-11-14 | Winningham Rick EDirector, CHIEF EXECUTIVE OFFICER | Grant or award A | +3,193 | 9.57 | 1,827,092 | Form 4 |
How to read it
- Buy, sale
- Code P and S on the form: shares bought or sold in the market, at the market price. The other codes are mostly pay (a grant, an option exercised) or tax (shares the company withheld), and say little about what the insider thinks of the price.
- Plan
- A sale or purchase under a Rule 10b5-1 plan, set up in advance and running on its own schedule. Since April 2023 the form has a box for it. Much executive selling is planned and says more about diversifying than about the company.
- Holds after
- The shares the insider still held after the trade, in the form the trade was in (directly, or indirectly through a trust or a fund).
- Value
- Shares times the price the form reports, which is often an average over several fills on the day.
Read from the SEC's own quarterly data sets of Forms 3, 4 and 5, and from each day's filings since the last one. A correcting amendment replaces the lines it restates. Every row links to its filing. None of this is advice: insiders sell for many reasons, and buy for fewer.